|
Age (years)
|
48.0 ± 14.6
|
54.2 ± 18.0
|
0.096
|
|
Sex (female)
|
14 (60.9%)
|
17 (53.1%)
|
0.568
|
|
Duration of corticotherapy (months)
|
17.5 ± 37.0
|
29.3 ± 54.2
|
0.444
|
|
Dose of corticosteroids (mg)
|
72.3 ± 53.3
|
37.6 ± 28.4
|
0.015
|
|
Hospitalization within last 90 days
|
20 (87.0%)
|
23 (71.9%)
|
0.182
|
|
Previous antimicrobial therapy within 30 days
|
22 (95.7%)
|
25 (78.1%)
|
0.120
|
|
Diabetes mellitus
|
5 (21.7%)
|
9 (28.1%)
|
0.592
|
|
Fever
|
19 (82.6%)
|
23 (71.9%)
|
0.355
|
|
Cough/expectoration
|
18 (78.3%)
|
27 (84.4%)
|
0.726
|
|
Respiratory failure at admission
|
10 (43.5%)
|
14 (43.8%)
|
0.984
|
|
Blood leukocyte count (109/L)
| | |
0.035
|
|
< 4
|
3 (13.0%)
|
4 (12.5%)
| |
|
4–10
|
14 (60.9%)
|
9 (28.1%)
| |
|
> 10
|
6 (26.1%)
|
19 (59.4%)
| |
|
Blood neutrophil count (109/L)
|
8.17 ± 5.99
|
9.13 ± 5.03
|
0.246
|
|
Blood lymphocyte count (/μL)
|
516 ± 291
|
1143 ± 1255
|
0.015
|
|
Albumin (g/L)
|
28.9 ± 4.8
|
30.2 ± 4.9
|
0.259
|
|
Urea (mmol/L)
|
9.71 ± 5.61
|
8.99 ± 7.37
|
0.187
|
|
C-reactive protein (mg/L)
|
66.0 ± 59.8
|
79.0 ± 69.7
|
0.703
|
|
PCT (ng/ml)
| | |
0.899
|
|
< 0.5
|
15 (65.2%)
|
20 (62.5%)
| |
|
0.5–2
|
3 (13.0%)
|
6 (18.8%)
| |
|
2–10
|
4 (17.4%)
|
4 (12.5%)
| |
|
> 10
|
1 (4.4%)
|
2 (6.2%)
| |
|
CMV viremia
|
12 (52.2%)
|
6 (18.8%)
|
0.009
|
